Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety
Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives
Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs
Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders
Joseph Tucker Recent News
Enveric Bio Stock Spikes 115% After Its Novel Prodrug Of Psilocin Receives Notice Of Allowance From US Patent And Trademark Office
Enveric Biosciences Reports Q1 2023 Loss, Implements Deep Staff Cuts & Halting Spinoff
EXCLUSIVE: In Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
Cannabis For Arthritis: Enveric Biosciences Files Patent On CBD Medication For Osteoarthritis
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
Another Psychedelics Company Joins 'Exclusive Nasdaq Group' With Enveric's Acquisition Of MagicMed Industries
Video: Experts Discuss Use of Psychedelics in Mental Health Settings
4 Psychedelics Experts On Adoption In Mainstream Medicine: 'A Mental Health Revolution'